Visiting/Using the site requires accepting our privacy policies - Click to accept

Precision Nanomedicine

The official journal of CLINAM

Precision Nanomedicine (PRNANO) is an open-access, not-for-profit journal that promotes all practical, rational and progressive aspects of nanomedicine.

Authors are invited to submit both original and replication studies. Discussions of negative results are also welcome.


PRNANO is digitally distributed by a scientists-owned non-profit publisher: Andover House Inc, 138 River Rd, Massachusetts, 01810, USA. E-ISSN: 2639-9431

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
- Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ.
Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer
- Khongkow M, Liu TY, Bartlett S, Hussein WM, Nevagi R, Jia ZF, Monteiro MJ, Wells J, Ruktanonchai UR, Skwarczynski M, Toth I.
Specific Molecular Recognition as a Strategy to Delineate Tumor Margin Using Topically Applied Fluorescence Embedded Nanoparticles
- Barton S, Li B, Siuta M, Janve VA, Song J, Holt CM, Tomono T, Ukawa M, Kumagai H, Tobita E, Wilson K, Sakuma S, Pham W.
Nanotherapy Targeting NF-kappaB Attenuates Acute Pain After Joint Injury
- Yan H, Duan X, Collins KH, Springer LE., Guilak FE, Wickline SA, M. Rai F, Pan H, Pham CTN
Simultaneous release of two drugs from polymer nano-implant inhibits recurrence in glioblastoma spheroids
- Devassy G, Ramachandran R, Jeena K, Junnuthula VR, Gopinatha VK, Manju CA, Manohar M, Nair SV, Raghavan SC, Koyakutty M.
Download PDF Views: 358     Downloads: 128

Specific Molecular Recognition as a Strategy to Delineate Tumor Margin Using Topically Applied Fluorescence Embedded Nanoparticles

Research Article

Shawn Barton2, Bo Li2, Michael Siuta2, Vaibhav A Janve2, Jessica Song2, Clinton M. Holt2, Takumi Tomono1, Masami Ukawa1, Hironori Kumagai3, Etsuo Tobita3, Kevin Wilson2, Shinji Sakuma1* and Wellington Pham5, 7, 8, 9, 10, 12[1]

1Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan

2Vanderbilt University Institute of Imaging Science, Nashville, TN

3Life Science Materials Laboratory, ADEKA Corp., Tokyo, Japan

4Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN

5Department of Biomedical Engineering, Vanderbilt University, Nashville, TN

6Vanderbilt Ingram Cancer Center, Vanderbilt School of Medicine Nashville, TN

7Vanderbilt Brain Institute, Nashville, Vanderbilt University, TN

8Vanderbilt Institute of Chemical Biology, Nashville, TN

Submitted: July 18, 2018 Accepted: October 27, 2018